Last updated: December 1, 2023
Sponsor: McMaster University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Brain Function
Treatment
Placebo
Low Dose β-OHB
High Dose β-OHB
Clinical Study ID
NCT06032156
kCBF
Ages 18-35 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Between the ages of 18 and 35
Exclusion
Exclusion Criteria:
- Presence of obesity (body mass index > 30 kg/m^2)
- Presence of known cardiovascular disease
- Presence of type 2 diabetes
- History of cardiovascular events requiring hospitalization (i.e., heart attack)
- History of concussion(s) with persistent symptoms
- Currently following a ketogenic diet and/or taking ketone body supplements
Study Design
Total Participants: 20
Treatment Group(s): 3
Primary Treatment: Placebo
Phase:
Study Start date:
November 08, 2023
Estimated Completion Date:
August 31, 2024
Connect with a study center
McMaster University
Hamilton, Ontario L8S 4K1
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.